Literature DB >> 30188339

Development of a Boston Treatment Program for Youth at Clinical High Risk for Psychosis: Center for Early Detection, Assessment, and Response to Risk (CEDAR).

Michelle S Friedman-Yakoobian1, Michelle L West, Kristen A Woodberry, Keira E O'Donovan, Suzannah V Zimmet, Andréa Gnong-Granato, Anthony J Giuliano, Margaret E Guyer, Janine Rodenhiser-Hill, Matcheri S Keshavan, Larry J Seidman.   

Abstract

Over the past two decades, increasing attention has been given to the importance of early intervention for psychosis. This article describes the development of the Center for Early Detection, Assessment and Response to Risk (CEDAR), which focuses on early identification and treatment of youth at clinical high risk for psychosis. There are relatively few models in the United States for such programs, and we present our developmental story, focusing mainly on the CEDAR Clinic, as a case study of how such a program can develop. We describe the rationale, infrastructure, and services provided at the CEDAR Clinic, and present some descriptive data from the CEDAR Clinic through 2016. A case example is provided to illustrate treatment at CEDAR. We hope that the cultural history of our program's development is informative for clinicians and policy makers as one model of how to build an early intervention service. We believe that this article is timely in view of the growing momentum in the United States for developing programs for intervening as early as possible for youth at clinical high risk for psychosis.

Entities:  

Mesh:

Year:  2018        PMID: 30188339      PMCID: PMC6130908          DOI: 10.1097/HRP.0000000000000181

Source DB:  PubMed          Journal:  Harv Rev Psychiatry        ISSN: 1067-3229            Impact factor:   3.732


  64 in total

Review 1.  Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis.

Authors:  Diana O Perkins; Hongbin Gu; Kalina Boteva; Jeffrey A Lieberman
Journal:  Am J Psychiatry       Date:  2005-10       Impact factor: 18.112

2.  Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents.

Authors:  Barbara A Cornblatt; Todd Lencz; Christopher W Smith; Ruth Olsen; Andrea M Auther; Emilie Nakayama; Martin L Lesser; Julia Y Tai; Manoj R Shah; Carmel A Foley; John M Kane; Christoph U Correll
Journal:  J Clin Psychiatry       Date:  2007-04       Impact factor: 4.384

Review 3.  The promise of early intervention.

Authors:  Jean Addington
Journal:  Early Interv Psychiatry       Date:  2007-11       Impact factor: 2.732

4.  The neuropsychology of schizophrenia: a neurodevelopmental and case study approach.

Authors:  L J Seidman
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1990       Impact factor: 2.198

5.  EPA guidance on the early intervention in clinical high risk states of psychoses.

Authors:  S J Schmidt; F Schultze-Lutter; B G Schimmelmann; N P Maric; R K R Salokangas; A Riecher-Rössler; M van der Gaag; A Meneghelli; M Nordentoft; M Marshall; A Morrison; A Raballo; J Klosterkötter; S Ruhrmann
Journal:  Eur Psychiatry       Date:  2015-03-03       Impact factor: 5.361

Review 6.  The psychosis high-risk state: a comprehensive state-of-the-art review.

Authors:  Paolo Fusar-Poli; Stefan Borgwardt; Andreas Bechdolf; Jean Addington; Anita Riecher-Rössler; Frauke Schultze-Lutter; Matcheri Keshavan; Stephen Wood; Stephan Ruhrmann; Larry J Seidman; Lucia Valmaggia; Tyrone Cannon; Eva Velthorst; Lieuwe De Haan; Barbara Cornblatt; Ilaria Bonoldi; Max Birchwood; Thomas McGlashan; William Carpenter; Patrick McGorry; Joachim Klosterkötter; Philip McGuire; Alison Yung
Journal:  JAMA Psychiatry       Date:  2013-01       Impact factor: 21.596

7.  Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.

Authors:  G Paul Amminger; Miriam R Schäfer; Konstantinos Papageorgiou; Claudia M Klier; Sue M Cotton; Susan M Harrigan; Andrew Mackinnon; Patrick D McGorry; Gregor E Berger
Journal:  Arch Gen Psychiatry       Date:  2010-02

Review 8.  Evidence-based early interventions for individuals at clinical high risk for psychosis: a review of treatment components.

Authors:  Elizabeth Thompson; Zachary B Millman; Nana Okuzawa; Vijay Mittal; Jordan DeVylder; Travis Skadberg; Robert W Buchanan; Gloria M Reeves; Jason Schiffman
Journal:  J Nerv Ment Dis       Date:  2015-05       Impact factor: 2.254

9.  Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.

Authors:  Gerard E Hogarty; Samuel Flesher; Richard Ulrich; Mary Carter; Deborah Greenwald; Michael Pogue-Geile; Matcheri Kechavan; Susan Cooley; Ann Louise DiBarry; Ann Garrett; Haranath Parepally; Rebecca Zoretich
Journal:  Arch Gen Psychiatry       Date:  2004-09

10.  Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: study design and baseline characteristics.

Authors:  Lisa J Phillips; Barnaby Nelson; Hok Pan Yuen; Shona M Francey; Magenta Simmons; Carrie Stanford; Margaret Ross; Daniel Kelly; Kathryn Baker; Philippe Conus; Paul Amminger; Francois Trumpler; Yang Yun; Michelle Lim; Catharine McNab; Alison R Yung; Patrick D McGorry
Journal:  Aust N Z J Psychiatry       Date:  2009-09       Impact factor: 5.744

View more
  4 in total

1.  An integrated neurocognitive and social-cognitive treatment for youth at clinical high risk for psychosis: Cognition for Learning and for Understanding Everyday Social Situations (CLUES).

Authors:  M Friedman-Yakoobian; E M Parrish; A Thomas; R Lesser; A Gnong-Granato; S Eack; M S Keshavan
Journal:  Schizophr Res       Date:  2019-02-05       Impact factor: 4.939

2.  Impact of "psychosis risk" identification: Examining predictors of how youth view themselves.

Authors:  Lawrence H Yang; Kristen A Woodberry; Bruce G Link; Cheryl M Corcoran; Caitlin Bryant; Daniel I Shapiro; Donna Downing; Ragy R Girgis; Gary Brucato; Debbie Huang; Francesca M Crump; Mary Verdi; William R McFarlane; Larry J Seidman
Journal:  Schizophr Res       Date:  2019-02-19       Impact factor: 4.939

3.  Longitudinal course and risk factors associated with psychosis in bipolar youths.

Authors:  Amit Shalev; John Merranko; Mary Kay Gill; Tina Goldstein; Fangzi Liao; Benjamin I Goldstein; Heather Hower; Neal Ryan; Michael Strober; Satish Iyengar; Martin Keller; Shirley Yen; Lauren M Weinstock; David Axelson; Boris Birmaher
Journal:  Bipolar Disord       Date:  2019-12-17       Impact factor: 6.744

4.  Computer-aided learning for managing stress: A feasibility trial with clinical high risk adolescents and young adults.

Authors:  Kristen A Woodberry; Cole Chokran; Kelsey A Johnson; Keith H Nuechterlein; David J Miklowitz; Stephen V Faraone; Larry J Seidman
Journal:  Early Interv Psychiatry       Date:  2020-04-01       Impact factor: 2.721

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.